Levity Hidden Fees: Visits, Labs, Shipping and Medication Costs

Last reviewed: September 24, 2026 Last updated: September 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Levity charges no separate membership fee, visit fee, lab fee, or shipping charge. The recurring price you see—ranging from $1,199 to $1,599 per four-week supply depending on which branded medication you choose—covers the FDA-approved injectable (Ozempic, Mounjaro, or Wegovy), provider consultation, ongoing care, and shipping. A first-month promotional discount of $50 is available (yielding first-month rates of $1,149 for Ozempic, $1,249 for Mounjaro, or $1,549 for Wegovy, captured September 4, 2026), after which the standard rate applies every ~4 weeks. Because Levity bills on a roughly four-week cycle, thirteen billing events occur over twelve months, pushing the effective monthly average higher than the per-cycle headline figure. For readers seeking branded GLP-1 medications without parsing line-item fees, Levity's structure is straightforward; for readers open to compounded alternatives, the price gap is substantial.

At-a-glance: Levity fee structure vs. PlexusDx

Levity pricing captured September 4, 2026 via intake verification; PlexusDx pricing captured September 24, 2026.

Breaking down Levity's all-inclusive pricing

Levity advertises "all-inclusive branded GLP-1 medication, care and shipping" with no separate membership or per-visit charges. The single recurring price covers your FDA-approved injectable, consultation with a licensed provider, ongoing clinical oversight, and delivery. Levity offers three medications—Ozempic (semaglutide), Mounjaro (tirzepatide), and Wegovy (semaglutide in higher-dose presentation)—each with its own price tier.

As of the September 4, 2026 capture, Levity's standard recurring rates are:

• Ozempic: $1,199 per four-week supply
• Mounjaro: $1,299 per four-week supply
• Wegovy: $1,599 per four-week supply

The first four-week cycle is discounted by $50, yielding first-month introductory rates of $1,149 (Ozempic), $1,249 (Mounjaro), or $1,549 (Wegovy). Starting with the second cycle, the standard rate applies and recurs every ~4 weeks. Because each cycle is roughly four weeks rather than a calendar month, thirteen billing events occur over twelve months, a detail that significantly affects your annual cost.

Levity permits cancellation anytime with no documented contract lock-in or renewal penalty, so you are not required to prepay multiple cycles.

Effective 12-month cost: why the four-week cadence matters

A per-cycle price of $1,199 might suggest an annual cost of $14,388 (twelve months × $1,199). In practice, Levity's ~4-week billing rhythm generates thirteen charges over the course of a year. The table below shows the true first-year outlay and the effective monthly average—our calculation based on one promotional cycle plus twelve standard-rate refill cycles:

Calculations assume one promotional cycle + twelve standard refill cycles to approximate twelve months of treatment. Levity pricing captured September 4, 2026.

For readers budgeting on a calendar-month basis, the effective monthly figure provides a more accurate planning benchmark than the per-cycle headline.

Branded FDA-approved vs. compounded: the medication difference

Levity dispenses only branded, FDA-approved GLP-1 injections manufactured by Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro). These products have completed the FDA's rigorous review process for safety, efficacy, and manufacturing quality, and each pen is produced in an FDA-inspected facility under a New Drug Application approval.

PlexusDx and many telehealth competitors offer compounded semaglutide and tirzepatide—medications prepared by licensed 503A compounding pharmacies to the same active-ingredient specification but without the finished-product FDA approval that branded drugs carry. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

The trade-off is price. PlexusDx compounded semaglutide injection costs $189 per month on a month-to-month plan ($2,268 over twelve months), and compounded tirzepatide injection costs $289 per month ($3,468 over twelve months). Both figures include provider visit, medication at every dose level, and shipping—the same all-in structure Levity uses, but at approximately one-seventh to one-sixth the annual outlay for the comparable molecule.

Some patients and prescribers prefer branded products for the assurance of FDA manufacturing oversight and the dose-delivery consistency of pre-filled pens. Others prioritize cost and accept compounded formulations when a licensed provider judges them clinically appropriate. Neither choice is categorically superior; the decision depends on your insurance situation, budget, and clinical discussion with your provider.

Are there genuinely hidden fees at Levity?

No. Levity's pricing model is transparent within its own structure: one recurring charge covers medication, consultation, care, and shipping, with no separate membership dues, per-visit bills, lab invoicing, or shipping surcharges. The term "hidden fee" does not apply in the sense of undisclosed line items appearing at checkout.

The nuance lies in understanding what that single price represents. Because the billing cycle is ~4 weeks rather than calendar monthly, thirteen payments occur over twelve months, which increases the true annual cost above a simple twelve-times multiplication. Additionally, the first-month promotional rate ($50 off) applies only once; every subsequent cycle bills at the higher standard rate. Readers who see "$1,199" and mentally budget $14,388 annually will find their actual spend closer to $15,537 for Ozempic—still no hidden fee, but a higher total than a naive calculation suggests.

In contrast, PlexusDx publishes calendar-monthly pricing ($189/month for compounded semaglutide injection, $289/month for compounded tirzepatide injection) with twelve billing events per year, making annual-cost estimation straightforward.

Comparison: Levity Ozempic vs. PlexusDx compounded semaglutide injection

Levity pricing captured September 4, 2026; PlexusDx pricing captured September 24, 2026.

Comparison: Levity Mounjaro vs. PlexusDx compounded tirzepatide injection

Levity pricing captured September 4, 2026; PlexusDx pricing captured September 24, 2026.

Decision factors: when branded FDA-approved matters, and when cost does

Levity's advantage is access to branded, FDA-approved pens with the full regulatory review and manufacturing oversight that some patients and prescribers prefer. If your insurance covers a portion of the cost (reducing your out-of-pocket below the list price), if you have an HSA or FSA that reimburses branded drugs more favorably than compounded formulations, or if your provider specifically prescribes Ozempic, Mounjaro, or Wegovy by name, Levity offers a straightforward fulfillment path with no membership overhead.

PlexusDx's advantage is cost. At $189/month for compounded semaglutide injection or $289/month for compounded tirzepatide injection, the twelve-month outlay is $2,268 or $3,468 respectively—less than one-fifth the branded equivalent at Levity. The clinical active ingredient, dose titration schedule, and injection route are comparable; the difference is the finished-product regulatory status and the per-pen manufacturing process. For patients paying entirely out-of-pocket and for whom a licensed provider judges compounded semaglutide or tirzepatide appropriate, the cost gap is the dominant decision variable.

Neither model hides fees in the traditional sense. Both bundle visit, medication, and shipping into one recurring charge. The practical distinction is branded versus compounded sourcing and the five-fold to six-fold price differential that distinction commands.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Choose Levity if…

• You carry insurance that partially reimburses branded Ozempic, Mounjaro, or Wegovy, lowering your effective out-of-pocket cost.
• Your prescriber specifies a branded product by name, or you and your provider prefer FDA-approved finished pens over compounded formulations.
• You value the regulatory oversight and dose-delivery consistency that come with branded manufacture.
• The $1,199–$1,599 per-cycle price fits your budget, and you are comfortable with the ~4-week billing cadence and the resulting thirteen charges per year.
• You want a single, predictable line item with no membership or per-visit fees to track separately.

Choose PlexusDx if…

• You are paying entirely out-of-pocket and the $2,268/year (semaglutide) or $3,468/year (tirzepatide) twelve-month cost is a deciding factor.
• A licensed provider determines that compounded semaglutide or tirzepatide prepared by a 503A pharmacy is clinically appropriate for you.
• You prefer calendar-monthly billing (twelve cycles per year) for easier budgeting and financial planning.
• You want the same all-in structure—visit, medication at every dose, shipping included—at approximately one-seventh the annual outlay of the branded equivalent.
• You accept that compounded medications do not carry the finished-product FDA approval that branded drugs do, and you are comfortable with that trade-off in exchange for cost savings.

Methodology and freshness

Levity pricing, fee structure, promotional terms, and medication availability were captured via intake verification on September 4, 2026. We advanced through Levity's online sign-up flow, observed the public pricing grid, applied a promotional discount in the interface, and recorded the first-month and standard recurring rates for Ozempic, Mounjaro, and Wegovy. No payment was submitted. PlexusDx pricing was captured from the live product catalog on September 24, 2026. The 12-month cost calculations and effective monthly averages presented in this article are our own, derived by summing one promotional cycle plus twelve standard-rate refill cycles for Levity (to approximate twelve months under a ~4-week cadence) and twelve calendar months at the published rate for PlexusDx. We label all such derived figures as "our calculation." Review profiles were checked on Trustpilot on September 4, 2026 (Levity) and September 9, 2026 (PlexusDx). If you are reading this article weeks or months after publication, confirm current pricing, promotional availability, and terms at checkout before committing.

Frequently Asked Questions

Does Levity charge a membership fee or separate visit fees?

No. Levity charges no membership fee, and provider consultations, ongoing care, and shipping are all included in the single recurring medication price. You pay one amount every ~4 weeks, covering everything.

Why is Levity's annual cost higher than twelve times the per-cycle price?

Levity bills every ~4 weeks rather than every calendar month, resulting in thirteen billing cycles over twelve months. After the discounted first month, you pay the standard rate twelve more times, pushing the true twelve-month total above a simple twelve-times multiplication of the headline per-cycle figure.

How much does Levity cost over twelve months for Ozempic?

Using the first-month promotional rate of $1,149 and the standard rate of $1,199 for the next twelve cycles, the twelve-month total is $15,537—our calculation—yielding an effective monthly average of approximately $1,294.75.

What is the difference between Levity's branded medications and PlexusDx's compounded injections?

Levity dispenses FDA-approved branded pens (Ozempic, Mounjaro, Wegovy) manufactured by Novo Nordisk and Eli Lilly. PlexusDx offers compounded semaglutide and tirzepatide prepared by licensed 503A pharmacies. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Can I cancel Levity anytime, or is there a minimum commitment?

Levity permits cancellation anytime with no documented contract lock-in. You are billed on a recurring ~4-week cycle, but you are not required to prepay multiple cycles or commit to a fixed term.

Sources

• PlexusDx product catalog, accessed September 24, 2026
• Levity public homepage and medication overview, accessed September 4, 2026
• Levity pricing page and intake verification flow (no payment submitted), accessed September 4, 2026
• Trustpilot profile for Levity (joinlevity.com), accessed September 4, 2026
• Trustpilot profile for PlexusDx (plexusdx.com), accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.